Filter
1251
Filtered Results: 1251
Text search:
pharmaceutical
performance
Featured
Recommendations
109
New Publications
380
Language
Document type
No document type
707
Studies & Reports
205
Guidelines
173
Strategic & Response Plan
65
Manuals
64
Training Material
16
Fact sheets
10
Situation Updates
8
Resource Platforms
3
Countries / Regions
Ethiopia
58
India
55
Kenya
51
Global
45
Uganda
36
South Africa
32
Nigeria
31
Sierra Leone
29
Liberia
29
Ghana
24
Namibia
24
Rwanda
23
Tanzania
22
Zambia
22
Western and Central Europe
21
Nepal
19
Malawi
18
Africa
18
Bangladesh
18
Ukraine
13
Latin America and the Carribbean
13
Philippines
12
Cambodia
12
Zimbabwe
11
Eastern Europe
11
Indonesia
11
Lesotho
10
Syria
10
Congo, Democratic Republic of
9
Myanmar / Burma
9
West and Central Africa
8
Botswana
8
South–East Asia Region
7
Cameroon
6
Senegal
6
Eswatini/ Swaziland
6
Benin
5
East and Southern Africa
5
Thailand
4
Guinea
4
Asia
4
Albania
3
Burkina Faso
3
Germany
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Brazil
3
South Sudan
3
China
2
Jordan
2
Middle East and North Africa
2
Jamaica
2
Lebanon
2
Vietnam
2
Egypt
2
Iraq
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
Chile
1
Iran
1
Fiji
1
Laos
1
Kyrgyzstan
1
Niger
1
Afghanistan
1
Peru
1
Bulgaria
1
Mozambique
1
Haiti
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Japan
1
United Kingdom
1
Southern Africa
1
Papua New Guinea
1
Moldova
1
Sudan
1
Mali
1
Chad
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
587
Clinical Guidelines
69
Public Health
68
Key Resources
61
Pharmacy & Technologies
28
Women & Child Health
25
Capacity Building
11
Toolboxes
Pharmacy
97
COVID-19
77
AMR
77
TB
73
Mental Health
57
HIV
49
NTDs
39
Planetary Health
29
NCDs
27
Rapid Response
26
Caregiver
25
Health Financing Toolbox
23
Global Health Education
22
Conflict
20
Malaria
17
2.0 Rapid Response
11
Ebola & Marburg
10
Refugee
8
Polio
8
Specific Hazards
7
Disability
5
Natural Hazards
4
Cholera
2
Social Ethics
1
Zika
1
Building laboratory testing capacity
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
The Councils share a common mandate of ensuring persons practising health related professions in Namibia are suitably qualified. Registration with the Councils is, thus, a pre-requisite for professional practice – and it is also a legal requirement too update personal details of all registered hea...
The role of evidence in the journey towards universal health coverage is paramount. Financial risk protection monitoring, the major focus of this report, informs where the WHO African Region stands in reducing the financial hardship people face due to health expenses. This report details the status ...
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t...
In 2022, Namibia had an estimated population of 2.6 million people, where 51 per cent per cent are females and 52.5 per cent of households in urban areas, with fast-growing urban informal settlements which lack access to basic services. Namibia has a young population; 42 per cent are children (0-17 ...
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficiency virus (HIV). Despite recent decreases in the numb...
PLOS Glob Public Health 3(7): e0001132. https://doi.org/10.1371/journal.
pgph.0001132
This paper proposes a framework for strategic communications for malaria governance that involves five key elements: knowing the audience, defining the message, designing a medium, identifying a messenger, and ...
4th edition, Reference Manual
The framework recommends expanded coverage of malaria diagnostic and treatment services, intensified vector control to drive down transmission, strengthened malaria surveillance, and increased transborder collaboration, especially in terms of efforts to control the sale and use of artemisinin monoth...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S...
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat...
Malaria remains a significant public health concern in the SADC region, accounting for 20% of childhood deaths, as well as prompting numerous outpatient visits and hospitalisations. Around three-quarters of the population, including 35 million children under the age of five and 8.5 million pregnant ...
To contribute to the availability of basic knowledge and skills for the provision of palliative care in
the African region, the African Palliative Care Association (APCA) has developed a competencybased core curriculum framework for use in introductory training on palliative care. The curriculum ...
This document, with a focus on the built environment and health care facilities, intends to guide the audience in preparing for and responding to SARI pandemics caused by existing and novel pathogens. It provides technical guidance on designing, establishing, and managing health care facilities for ...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
